Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer

IJ Liu, MB Zafar, YH Lai, GM Segall, MK Terris - Urology, 2001 - Elsevier
Objectives. To determine the value of 18-fluoro-2-deoxyglucose (FDG) positron emission
tomography (PET) studies in the evaluation of patients with organ-confined prostate cancer. …

PET in differentiation of recurrent brain tumor from radiation injury

DD Langleben, GM Segall - Journal of Nuclear Medicine, 2000 - Soc Nuclear Med
The annual incidence of primary intracranial tumors is 7 to 19 cases per 100,000 people.
The general approach to the treatment of brain neoplasms is surgical resection of solitary …

Effects of anger on left ventricular ejection fraction in coronary artery disease

…, C Dennis, M Chesney, S Spitzer, GM Segall - The American journal of …, 1992 - Elsevier
This study examined the comparative potency of several psychological stressors and exercise
in eliciting myocardial ischemia as measured by left ventricular (LV) ejection fraction (EF) …

[PDF][PDF] Prone versus supine thallium myocardial SPECT: a method to decrease artifactual inferior wall defects

GM Segall, MJ Davis - Journal of nuclear medicine, 1989 - Soc Nuclear Med
0.001). Prone imaging resulted in a significantly higher specificity for RCA disease compared
to supine imaging (90% vs. 66%, p< 0.05) with an improvement in accuracy from 71% to 82…

Positron emission tomography is superior to computed tomography for metastatic detection in melanoma patients

…, LA Carroll, DL Johnson, GM Segall - Annals of Surgical …, 2002 - Springer
Background Whole-body positron emission tomography (PET) provides diagnostic information
not currently available with traditional imaging and may improve the accuracy of staging …

Uses and limitations of FDG positron emission tomography in patients with head and neck cancer

MM Hanasono, LD Kunda, GM Segall, GH Ku… - The …, 1999 - Wiley Online Library
Objective: Numerous authors have reported the potential usefulness of positron emission
tomography (PET). These studies have had conflicting results, at least partly owing to limited …

Status of and trends in nuclear medicine in the United States

D Delbeke, GM Segall - Journal of Nuclear Medicine, 2011 - Soc Nuclear Med
Nuclear medicine in the United States has grown because of advances in technology, including
hybrid imaging, the introduction of new radiopharmaceuticals for diagnosis and therapy, …

[PDF][PDF] A mathematical model for the distribution of fluorodeoxyglucose in humans

MT Hays, GM Segall - Journal of Nuclear Medicine, 1999 - Soc Nuclear Med
Fluorodeoxyglucose in Humans Page 1 ith the increasing use of â€8F-fluorodeoxyglucose (FDG)
in clinical nuclear medicine, it is important to delineate its normal distribution in humans…

Evaluation of fluorodeoxyglucose positron emission tomography imaging in metastatic transitional cell carcinoma with and without prior chemotherapy

…, GM Segall, S Srinivas, M Nino-Murcia… - Urologia …, 2006 - karger.com
Introduction: This study was designed to determine the value of fluorodeoxyglucose (FDG)
positron emission tomography (PET) in the evaluation of metastatic transitional cell carcinoma …

SPECT and PET in the evaluation of coronary artery disease

H Jadvar, HW Strauss, GM Segall - Radiographics, 1999 - pubs.rsna.org
Cardiac positron emission tomography (PET) is an accurate method for assessing myocardial
perfusion and metabolism in the evaluation of coronary heart disease. PET allows more …